Navigation Links
BioMarin to Present at the UBS Global Life Sciences Conference
Date:9/15/2009

NOVATO, Calif., Sept. 15 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update at the UBS Global Life Sciences Conference in New York City on Tuesday, September 22, 2009 at 4:00 p.m. ET.

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is in clinical development for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development for the treatment of MPS IVA. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.


'/>"/>
SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. BioMarin to Present at the Thomas Weisel Partners Healthcare Conference
2. BioMarin Announces Second Quarter 2009 Financial Results
3. BioMarin to Host Second Quarter 2009 Financial Results Conference Call and Webcast on Thursday, July 30 at 5:00 p.m. ET (23:00 CET)
4. BioMarin to Present at the William Blair Growth Stock Conference
5. BioMarin Receives 2009 Corporate Award for the Development of Kuvan
6. BioMarin to Present at the Cowen and Company 29th Annual Health Care Conference
7. BioMarin to Present at the Barclays Capital Global Healthcare Conference
8. BioMarin Appoints Dr. Henry J. Fuchs as Senior Vice President and Chief Medical Officer
9. BioMarin Supports Observance of Rare Disease Day February 28
10. BioMarin to Present at the 27th Annual J.P. Morgan Healthcare Conference
11. BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...PRNewswire/--TheGuardianLifeInsuranceCompanyofAmer...aleadingproviderofemployeebenefitsforsmallandmid-s...inuetofollowitscurrentinsurancecoverageguidelinesf...ntwiththeAmericanCancerSocietyandAmericanMedicalAs...ngs. ,, Recently,TheU.S.PreventiveServicesTaskF...
(Date:11/24/2009)...adetoUSPSTFRepresentationandRecommendationProcess ...SeveralsectionsofSenatehealthcarereformlegislation...chasprivateinsurers,MedicareandMedicaidwouldonlybe...theU.S.PreventativeServicesTaskForce.Presently,thi...donlyrequirecoverageofbiennial(everyotheryear)cove...
(Date:11/24/2009)...vember 24, 2009 Researchers at Ben-Gurion Univers...detects cancerous skin tumors, including melanomas...initial testing, the OSPI instrument (Optical Spec... lesions that have never been seen before - includ...arious skin lesions and were awaiting surgery for ...
(Date:11/24/2009)...ng family members of pediatric cancer and hematolo...mily and the medical team, according to a new Indi...y Hospital for Children, where the study was condu...ls nationwide routinely offering the parents of pe...nity to join their child,s medical team as active ...
(Date:11/24/2009)...old its Conjoint Mid-Winter Meetings Jan. 27Feb. 2...buquerque, N.M. This year, SNM joins its annual Mi...l Meeting and Educational Symposium of the America...cine and Molecular Imaging Summit and the Clinical...event offers participants an outstanding range of ...
Breaking Medicine News(10 mins):Health News:USPSTF Mammography Recommendations Should Be Specifically Excluded From Health Care Reform Legislation 2Health News:USPSTF Mammography Recommendations Should Be Specifically Excluded From Health Care Reform Legislation 3Health News:New device enables early detection of cancerous skin tumors -- Ben Gurion U. 2Health News:Involving family in medical rounds benefits both family and medical team 2Health News:Involving family in medical rounds benefits both family and medical team 3Health News:Involving family in medical rounds benefits both family and medical team 4Health News:SNM's Conjoint Mid-Winter Meetings offer 4 scientific meetings in 1 location 2
...esearch shows it does not damage cerebral blood ve...HealthDay News) -- Two studies looking at the same...s linked with brain shrinkage, it does not seem to... lesions that indicate "silent strokes," is the me...
...ON CITY, Calif., Jan. 12 Abaxis, Inc. (Nasdaq: ...oint-of-care blood analysis systems, announced tod...ve officer, will present at the Sidoti & Compa...at The Ritz-Carlton, Palm Beach, Florida. , , Ab...
...nuary 12, 2009 -- New research conducted at Columb...cates that the advertising of alcohol in predomina...ty may add to problem drinking behavior among resi...advertising on alcohol consumption has been unclea...
... Partnership Will Fund Breakthrough Research to Su...r TNBC Patients , , DALLAS, Jan. 12 When her doc...thought detecting it early had greatly enhanced he...riple negative breast cancer. , , (Logo: http://...
... tiny particle syringe composed of polymer layers ...argets diseased cells without harming the rest of ...s. This delivery system could be robust and flexib... Huda A. Jerri, graduate student, chemical enginee...
...searchers at The University of Arizona are develop... the lives of people with Down syndrome. , The c... 800 to 1,000 live births, is signaled by the pres...heart defects and the early onset of Alzheimer,s d...
Other Medicine News:Health News:HRT Shrinks the Brain 2Health News:HRT Shrinks the Brain 3Health News:Outdoor alcohol advertising and problem drinking among African-American women in NYC 2Health News:Susan G. Komen for the Cure(R) and Triple Negative Breast Cancer Foundation Unite to Fight Aggressive Form of Breast Cancer 2Health News:Susan G. Komen for the Cure(R) and Triple Negative Breast Cancer Foundation Unite to Fight Aggressive Form of Breast Cancer 3Health News:Tiny capsules deliver 2Health News:Standardized test battery to aid those with Down syndrome 2Health News:Standardized test battery to aid those with Down syndrome 3Health News:Standardized test battery to aid those with Down syndrome 4Health News:Standardized test battery to aid those with Down syndrome 5Health News:Standardized test battery to aid those with Down syndrome 6
(Date:11/24/2009)...,Ind.,Nov.24/PRNewswire-FirstCall/--ZimmerHoldings...ticipatinginthe21stAnnualPiperJaffrayHealthCareCon...m.EasternTime. ,, Alivewebcastofthepresentation... http://investor.zimmer.com .Thewebcastwillbearchi...eCompany ,, Foundedin1927andheadquarteredinWar...
(Date:11/24/2009)...GO,Nov.24/PRNewswire-FirstCall/--Orexigen®The...mpanyfocusedonthetreatmentofobesity,todayannounced...Company,sBoardofDirectorsgrantedaninducementstocko...Klassen,M.D.,itsnewlyappointedHeadoftheGlobalContr...centivestockoptiontotheextentpermittedbylawandhasa...
(Date:11/24/2009)...EO,Calif.,Nov.24/PRNewswire-FirstCall/--NeurogesX,...edondevelopingandcommercializingnovelpainmanagemen...intoitsBoardofDirectors,effectiveNovember19,2009.M...harmaceuticalindustryandhasbeeninstrumentalinthela...currentlyservesasSeniorVicePresident,BioOncologyBu...
Breaking Medicine Technology:Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 2NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 3Springborn Deploys eStudy 28TM 29 Hosted Solution for Management of Global Environmental Testing 12656 1Springborn Deploys eStudy 28TM 29 Hosted Solution for Management of Global Environmental Testing 12656 2Springborn Deploys eStudy 28TM 29 Hosted Solution for Management of Global Environmental Testing 12656 3Matrixx Initiatives Inc Received a Warning Letter From the Food and Drug Administration 49103 1Matrixx Initiatives Inc Received a Warning Letter From the Food and Drug Administration 49103 2Matrixx Initiatives Inc Received a Warning Letter From the Food and Drug Administration 49103 3Fruits and Veggies May Improve Sperm Quality 49099 1Fruits and Veggies May Improve Sperm Quality 49099 2
...l training to help brain adapt more fully and furt...udy of specially designed peripheral prism glasses...al field in both eyes), scientists found that two-...t the end of the study period and beyond, indicati...he brains of patients had not fully remapped to ad...
...M) Stent now available in select markets worldwide...poration (NYSE: BSX ) today announced the launch...litaxel-Eluting Coronary Stent System in select ma... a new platinum chromium alloy engineered specific...s the Company,s third-generation drug-eluting sten...
Other Medicine Technology:Study Confirms Effectiveness of Innovative Prism Glasses For Hemianopia Patients 2Study Confirms Effectiveness of Innovative Prism Glasses For Hemianopia Patients 3Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 2Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 3Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 4Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 5
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: